Therapeutic Goods Administration News | Page 5 of 11 | Cannabiz

TGA’s delta-8 crackdown leaves patients in limbo

by Martin Lane April 21, 2022April 29, 2024

Australian patients using products containing delta-8 THC to manage conditions including PTSD, chronic pain, anxiety and […]

SAS-B approvals continue to rebound

by Steve Jones April 12, 2022April 29, 2024

TGA insists there will be no shortage of medicinal cannabis in Australia

by Martin Lane April 7, 2022April 29, 2024

Specialist firm urges TGA to rethink position on delta-8 THC

by Martin Lane March 31, 2022April 29, 2024

TGA unveils details of changes to medicinal cannabis quality, packaging and labelling requirements

by Rhys Cohen March 29, 2022April 29, 2024

‘It’s not legal in Australia’: TGA boss pulls no punches on delta-8 THC

by Rhys Cohen March 17, 2022April 29, 2024

Bid to increase veterinary access to medicinal cannabis hits buffers

by Martin Lane March 14, 2022April 29, 2024

AMCA and MCIA tell industry: ‘put your own house in order’

by Martin Lane March 3, 2022April 29, 2024

It’s time for the industry to walk the talk when conducting itself

by Peter Crock March 3, 2022April 29, 2024

What NOT to do when advertising medicinal cannabis products

by Dr Teresa Nicoletti March 3, 2022April 29, 2024